BBP · Virtus Biotech ETF
United States · RS rating 91 · As of 2026-10-14
| Price | 101.80 USD |
|---|---|
| 1-day change | +1.1% |
| RS rating (overall / 1M / 3M / 12M) | 91 / 74 / 80 / 87 |
| Stage | Topping |
| Composite / Minervini / CANSLIM score | 38 / 50 / 32 |
| Industry group (rank) | Finance-ETF / ETN (48) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | – |
| Distance from 52-week high | +7.4% |
| Market cap (USD) | – |